AKT1 and neoplasm: This resulted in decreased c-Src signaling via the PI3K/Akt survival pathway, inhibiting tumor cell proliferation in vitro and decreasing tumor growth in vivo when the tumor cells were xenografted in BALB/c nude mice [113].